Doctor profile · Federal record
Dr. Aliya Khan, MD
Rheumatology Physician (CMS: Rheumatology) · Clinical & Laboratory Immunology (Internal Medicine) Physician · Dayton, OH
- NPI 1487638870
- Accepts Medicare
- MIPS 91.2 / 100 · 2023
- 37 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3075 Governors Place Blvd, Suite 110
Dayton, OH 454091332
(937) 296-0015
fax (937) 296-0074
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- October 5, 2011
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Ohio #35063979
- Medicaid
- OH #2037727
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1487638870. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
120,512
Distinct HCPCS
10
Medicare allowed
$2,048,260
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 83,960 | 14 | $6 | |
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 14,784 | 16 | $48 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,875 | 13 | $42 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 4,240 | 18 | $38 | |
J0897 |
Injection, denosumab, 1 mg | 3,900 | 42 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 3,440 | 16 | $33 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 536 | 18 | $19 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 517 | 61 | $60 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 465 | 256 | $123 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 192 | 39 | $122 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 2,935. This provider delivers 41× the peer median.Open Payments
Industry payments received
All-time total
$310
Transactions
15
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 4 | $66.26 | |
| Amgen Inc. | 2 | $50.42 | |
| Novartis Pharmaceuticals Corporation | 2 | $37.92 | |
| Organon Llc | 2 | $31.43 | |
| Janssen Biotech, Inc. | 1 | $29.20 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26.00 | |
| Aurinia Pharma U.S., Inc. | 1 | $24.69 | |
| DePuy Synthes Sales Inc. | 1 | $24.35 | |
| Mallinckrodt Hospital Products Inc. | 1 | $19.98 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,243
Patients
417
Total drug cost
$405,190
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 354 | 123 | $30,675 |
| Prednisone | Generic | 203 | 72 | $1,925 |
| Methotrexate (Methotrexate Sodium) | Brand | 190 | 76 | $8,424 |
| Leflunomide | Generic | 84 | 30 | $6,577 |
| Gabapentin | Generic | 74 | 22 | $1,274 |
| Tramadol Hcl | Generic | 45 | 17 | $473 |
| Duloxetine Hcl | Generic | 40 | 16 | $1,287 |
| Humira(Cf) Pen (Adalimumab) | Brand | 38 | 0 | $345,187 |
| Celecoxib | Generic | 37 | 14 | $1,511 |
| Allopurinol | Generic | 32 | 0 | $485 |
Frequently asked questions
What is Dr. Aliya Khan's medical specialty?
Dr. Aliya Khan practices Rheumatology Physician in Dayton, OH.
Where does Dr. Aliya Khan practice?
Dr. Aliya Khan practices at 3075 Governors Place Blvd, Dayton, OH 454091332. Office phone: 9372960015.
What is Dr. Aliya Khan's NPI?
Dr. Aliya Khan's National Provider Identifier (NPI) is 1487638870, issued by NPPES.
Does Dr. Aliya Khan accept Medicare assignment?
Yes. Dr. Aliya Khan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Aliya Khan commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS J1561); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.